Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06293300

Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A)

Led by University of Miami · Updated on 2025-09-02

50

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

Sponsors

U

University of Miami

Lead Sponsor

U

United States Department of Defense

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this research is to understand and treat Traumatic Brain Injury (TBI) associated photophobia (light sensitivity) and its impact on visual function.

CONDITIONS

Official Title

Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male and female subjects, civilians and veterans (expected 1:1 mix) of all races and ethnicities
  • 18 years of age or older and able to consent
  • Chronic photophobia with a score of 4 or higher on a 0-10 scale, lasting at least 6 months
  • Remote history of TBI occurring more than 1 year ago, based on Department of Defense TBI criteria with documented ICD9/ICD10 codes
  • Stable medication regimen for the past 3 months
  • No prior Botulinum Toxin Type A treatment for orofacial conditions
  • English is the primary language by self-report
Not Eligible

You will not qualify if you...

  • Presence of ocular diseases that could affect photophobia, including glaucoma, corneal or conjunctival scarring, corneal edema, uveitis, iris transillumination defects, or retinal degeneration
  • Participation in another investigational drug study within 1 month prior to screening
  • Pregnancy or potential pregnancy without a negative pregnancy test within 24 hours of MRI scans
  • Contraindications to fMRI scanning, such as metal implants or pacemakers

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Miami

Miami, Florida, United States, 33136

Actively Recruiting

Loading map...

Research Team

A

Anat Galor, MD/MSPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here